000			01171nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aPharmacogenomics _bFrom Basic Research to Clinical Implementation
546			_aEnglish[eng]
650			_apharmacogenomics||return of results||genetic counseling||qualitative||pharmacogenetics||implementation||pharmacogenetics service||screening||pre-emptive||personalized medicine||precision medicine||community pharmacy||pharmacogenomic testing||genetic privacy||pharmaco-economics||polymorphisms||pharmacogenes||pharmacogenomic||machine learning||adaptation||human evolution||US Food and Drug Administration||clinical actionability||clinical translation||chronic kidney disease||CYP3A5||polymorphism||progression||pharmacogenomics (PGx)||pediatrics||best practice alerts (BPAs)||electronic health records (EHR)||genomic indicators||clinical decision support (CDS)||phenotype||genotype||polypharmacy||chronic disease||medication management||electronic medical record||artificial intelligence||n/a
700			_aScheinfeldt, Laura B.
856			_uhttps://mdpi.com/books/pdfview/book/5095
942			_cEB
999			_c21823 _d21823